Magdalena Krekora is a Doctor of Laws (title of her dissertation: “Guarantees of intellectual property protection in marketing authorisation procedure of medicinal products  in Poland on comparative ground (EU and USA)”). Her doctor’s degree she got at Jagiellonian University.

Magdalena Krekora graduated Jagiellonian University, Faculty of Law in 1996. She also completed post-graduate studies on industrial property law at Jagiellonian University. Jagiellonian University is one of the oldest and one of the best universities in this part of Europe (it was founded in 1364).

From 1996 to 2002 she worked as a lawyer specialising in pharmaceutical law, European Union law and intellectual property law in international pharmaceutical company. In 1999 she completed traineeship in European Commission in Brussels, and in 2000 she was one of governmental experts preparing draft of pharmaceutical law adopted on the 6th of September 2001, and being in force today.

She is also an author or co-author of numerous publications on intellectual property law, pharmaceutical law, and European Union law.


Since 2006 she takes part, as an international expert on intellectual property law, pharmaceutical law, food law, and European Union law, in international projects in Asia, Middle East, Africa, North America and South America financed by the European Commission or the European Bank for Reconstruction and Development (EBRD).

She lectured intellectual property law at Cracow University of Technology, and patent law at post-graduate studies on “Business in Biotechnology” organised by Jagiellonian University. She conducted numerous seminars, and workshops in Polish and in English on the topics of intellectual property law, pharmaceutical law, and copyright law.

Magdalena Krekora represents clients before the Polish Patent Office, the European Patent Office, the European Union Intellectual Property Office, the Court of Justice of the European Union, Polish civil and administrative courts, arbitration institutions, and public authorities such as sanitary inspection, pharmaceutical inspection, or the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products.